Zimmer Biomet Holdings, Inc.

NYSE:ZBH

Medical - Devices

Healthcare
$103.32 +1.00%

+$0.87 today

Market cap
$19.55B
Beta
0.47
P/E (TTM)
22.5
EPS (TTM)
$3.90
Dividend yield
1.09%
52W Low $79.12High $108.29

Volume 2.34M

Average 2.28M

ZBH Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

Zimmer Biomet Holdings, Inc.NYSE: ZBH

Capital Expenditures · Q2 FY2026 · quarter ended Jun 2026

Capital expenditures grows, but more slowly than its trailing trend

Q2 FY2026 capital expenditures of $116.4M (cash outflow) rose 45.3% year over year, behind the +136.3% change in trailing-twelve-month capital expenditures. Sequentially, it rose 54.6% from the prior quarter. Over 3 fiscal years it compounded at +1.0% a year.

Context

  • Capital expenditures amounted to 2.7% of revenue in FY2025, down 1.9 pp from a year earlier.
  • Capital expenditures grew in size in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from +45.3% toward the trailing-twelve-month pace of +136.3%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$116.4M+54.6% QoQ
Last fiscal yearDec 2025
-$224.5M-37.1% YoY
LTMJun 2026
$86.8M+136.3% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+45.3%——
1 year-37.1%——
3-year CAGR+1.0%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

USD · from the cash flow

Latest · FY2025
(224.5M) USD
Year-over-year change
+37.1%

Capital Expenditures vs competitors

How ZBH compares with its peers on the latest reported figures

  • Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +136.3% is the highest of 10, against a peer median of +21.4%.
  • Capital expenditures amounts to 1.0% of revenue for ZBH, versus a peer median of 4.3%.
ZBH Competitors
Capital Expenditures for ZBH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MDTMedtronic plcLTM Jul 2026$1.9B USD+3.3%+9.3%5.1%
BSXBoston Scientific CorporationLTM Jun 2026$904M USD-7.2%+12.7%4.3%
SYKStryker CorporationLTM Jun 2026$823M USD+10.9%+9.0%3.2%
GEHCGE HealthCare Technologies Inc.LTM Jun 2026$522M USD+21.4%+15.8%2.6%
SNNSmith & Nephew plcFY2025$433M USD+13.6%+6.5%7.0%
PHGKoninklijke Philips N.V.LTM Jun 2026€382.2M EUR+76.2%-16.8%2.2%
EWEdwards Lifesciences CorporationLTM Jun 2026$286.7M USD+53.3%-0.6%4.4%
ZBHZimmer Biomet Holdings, Inc.LTM Jun 2026$86.8M USD+136.3%+1.0%1.0%
OFIXOrthofix Medical Inc.LTM Mar 2026$38.54M USD+25.2%+14.3%4.7%
ALGNAlign Technology, Inc.LTM Jun 2026$0 USD+100.0%-29.5%0.0%
Peer median (excluding ZBH) —+21.4%+9.0%4.3%

Competitors are the stored peer set for ZBH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income445.5M291.2M1.03B905.2M705.1M
Depreciation & Amortization937.7M926.4M951.7M996.3M1.09B
Deferred Income Tax(102.1M)(64.4M)(96.3M)(47.7M)(87.2M)
Stock-Based Compensation76M105M99.8M101M90.2M
Change in Working Capital(134.2M)(311.4M)(396.2M)(455.4M)(104.9M)
Accounts Receivables(40.8M)(184.7M)(51.9M)(89.7M)(127.3M)
Inventory(8.4M)(75.6M)(240.4M)49.9M98.2M
Accounts Payables86.5M103M(55.3M)(322M)101.8M
Other Working Capital(171.5M)(154.1M)(48.6M)(93.6M)(177.6M)
Other Non-Cash Items276.3M337.9M(2.5M)0100K
Operating Cash Flow1.5B1.28B1.58B1.5B1.7B
Capital Expenditures(152M)(217.6M)(394.5M)(356.8M)(224.5M)
Acquisitions (Net)0(99.8M)(134.9M)(276.3M)(1.39B)
Purchases of Investments(273.6M)(258.3M)(311.7M)(240.3M)(300.5M)
Sales of Investments1.9M89.4M33.4M22.1M0
Other Investing Activities(88.3M)(72.6M)(74.6M)(189.8M)(57.5M)
Investing Cash Flow(503.6M)(529.2M)(778.9M)(888.1M)(1.98B)
Debt Repayment(1.06B)(1.06B)54.6M536.3M1.03B
Common Stock Issued122.5M00039.7M
Common Stock Repurchased0(126.4M)(692.2M)(868M)(487M)
Dividends Paid(200.1M)(201.2M)(200.9M)(196M)(190.3M)
Other Financing Activities(173.4M)544.5M75M43.2M(65.5M)
Financing Cash Flow(1.31B)(843.8M)(763.5M)(484.5M)326M
Effect of Forex Changes(13.2M)(14.5M)900K(17.1M)19M
Net Change in Cash(323.6M)(102.8M)40.1M109.7M66.4M
Free Cash Flow1.35B1.07B1.19B1.14B1.47B

Zimmer Biomet Holdings, Inc.

NYSE:ZBH

Intrinsic Alpha fair value

Locked

Current Price

$103.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.